The quarter fell short of the published revenue and EPS benchmarks. Revenue was $261 million versus one published consensus estimate of approximately $273 million, while diluted EPS was $0.40 versus approximately $1.18. The consensus data is less reliable for operating metrics, so no substantiated OIBDA beat/miss is available.
| Metric | Q2 2025 | Q2 2026 | Change | Published expectation |
|---|---|---|---|---|
| Revenue | $261M | $261M | 0% | ~$273M |
| Adjusted OIBDA | $108M | $96M | -11% | Not reliably available |
| Adjusted OIBDA margin | 41.4% | 36.8% | -460 bps | Not reliably available |
| Operating income | $51M | $29M | -43% | Not reliably available |
| Diluted EPS | $0.87 | $0.40 | -54% | ~$1.18 |
| Trailing-twelve-month free cash flow | $153M | $59M | -61% | Not reliably available |
The core issue was margin compression, not headline revenue. Revenue held flat because modest business-data growth offset a 2% consumer decline, but business direct costs rose 35% and technology expense increased 3%. That pushed Adjusted OIBDA down 11% and reduced the margin to 36.8%; operating income fell 43% even after excluding only $4 million of Quintillion acquisition costs. (Consolidated Financial Metrics)
The cash-generation picture weakened materially. Trailing-twelve-month operating cash flow declined to $308 million from $342 million, while free cash flow fell to $59 million from $153 million as capital expenditures rose to $259 million and grant proceeds dropped to $10 million. The company expects full-year 2026 net capital expenditures of $290 million, leaving less room for dividends and debt reduction than the headline operating-cash figure suggests. (Non-GAAP Financial Measures — Free Cash Flow reconciliation; Discussion of Results)
The new dividend is a meaningful capital-allocation positive, but it is conditional and arrives alongside higher leverage. Management intends to begin quarterly dividends of roughly $15 million in December 2026, but the policy can be modified, suspended or terminated and still requires formal declaration. Meanwhile, debt increased $228 million during the quarter, including a $160 million draw to fund the Quintillion loan; Liberty Capital leverage rose from 1.6x to 2.1x and GCI leverage from 2.3x to 2.8x. (Corporate Updates; Cash and Debt)
The net read is negative despite several supportive actions. The debt refinancing, $129 million repurchase of 2028 notes and planned dividend improve financial flexibility and shareholder returns, while Quintillion remains on track to close this year. But those positives do not offset the revenue/EPS shortfall, sharp OIBDA deterioration, higher capital spending and reduced free cash flow; the filing reshapes the story toward a higher-debt, lower-near-term-profitability transition. (Corporate Updates; Consolidated Financial Metrics; Cash and Debt)
Read the original 8-K on SEC EDGAR ↗